how APP interacts with components of the neuronal kinesin-I transport machinery.
ments from mouse brain and sciatic nerve extracts using shown), suggesting that this interaction is relatively robust. antibodies to kinesin-I subunits and APP (Figure 1) . Initially, we used two different kinesin-I antibodies includWe also noticed that a prominent difference between the coimmunoprecipitations from brain versus sciatic ing the monoclonal antibody 63-90 (Stenoien and Brady, 1997), which recognizes both KLC1 and KLC2, and a nerve extracts was that in the sciatic nerve extracts, a substantially larger fraction of the APP was brought polyclonal antibody directed to the ubiquitous KHC subunit (KIF5B). In brain and sciatic nerve extracts, both down relative to the brain extracts. Since the sciatic nerve is highly enriched for sensory and motor nerve kinesin-I antibodies coimmunoprecipitated APP in addition to kinesin-I subunits ( Figure 1A ). In contrast, the no axons and lacks nerve cell bodies (although Schwann cells and a few other nonneuronal cell types are present), antibody controls or a synaptotagmin antibody brought down no detectable APP or kinesin-I. In the complemenit is relatively enriched in the actively moving component of neuronal cargoes. Thus, these results raise the possitary coimmunoprecipitation experiment, a polyclonal anti-APP antibody directed against the last 9 residues bility that much of the APP in the actively transported compartment of neurons exists in a transport complex of the C terminus of APP precipitated significant amounts of APP and kinesin-I subunits. To test further with kinesin-I, whereas in whole brain there may be pools of APP that are pre-or posttransport and therefore the specificity of the coimmunoprecipitations, we also probed the immunoprecipitates with antibody probes not associated with kinesin-I. To evaluate further the specificity of the coimmunorecognizing synaptotagmin and synaptophysin, which are synaptic vesicle membrane proteins proposed to be precipitation experiments, similar experiments were conducted ( Figure 1B) Figure 1C) . Although all three KHC antibodies were able to coimmunoprecipitate APP from both genotypes, the amount of APP associated with KIF5B is reduced slightly in the KLC1 mutant, whereas there is a significant decrease in the amount of APP that comes down with the KIF5C antibody. The amount of APP that comes down with KIF5A is unchanged in wild type versus the KLC1 mutant. These results suggest that association of KIF5B or KIF5C with APP depends to a greater extent on KLC1 than KLC2, while association with KIF5A depends to a greater extent upon KLC2 than KLC1. Taken together, however, the data support the conclusion that coimmunoprecipitation of kinesin-I and APP is due to the formation of a complex in vivo, as opposed to nonspecific contamination of immunoprecipitates by APP, and that APP interacts with both KLC1and KLC2. Intriguingly, these data raise the possibility that the interaction of kinesin-I with APP might vary among different combinations of KHC and KLC subunits; further work is necessary to evaluate this suggestion.
We also examined the association of APP and KLC1 in sucrose gradients of membrane proteins from mouse brain extracts (Figure 2 ). When wild-type gradient fractions from mouse brain were probed with the KLC antibody 63-90, the KLC1 peak migrated around 9S (fractions 7-9), whereas the KLC2 peak migrated around 10.7S (fractions 8-10) as previously reported (Rahman we probed for two other membrane proteins (synaptotagmin and synaptophysin) in these gradients and found that they were unchanged from wild type (data not APP from fraction 8 of KLC1 mutant gradients (data not shown). It is interesting that soluble kinesin has been shown To test for direct interactions between the cyto-KLC1 itself was absent in the mutant. Examination of APP revealed that it sedimented with microtubules, both plasmic C-terminal domain of APP and KLC, we conducted in vitro binding assays using GST fusion proteins in the presence of ATP and AMP-PNP in the wild-type mouse brain extracts. Strikingly, APP did not cosedi-( Figure 5A ). GST fused to full-length KLC1 (GST-KLC1) or full-length KLC2 (GST-KLC2) was incubated with a ment with microtubules in the presence of ATP or AMP-PNP in the mutant KLC1 mouse brain extracts. Why APP protein consisting of the C-terminal tail of APP fused to GFP (APP-GFP). APP-GFP bound to both GST-KLC1 associates with microtubules in the presence of ATP is unclear, but it is possible that APP preferentially associand GST-KLC2 but not to GST alone. In addition, the GST-KLC1 and GST-KLC2 proteins also bound to an ates with the small fraction of kinesin-I that we and others routinely observe to bind microtubules even with overlapping region of the C-terminal stalk of KIF5B (KIF5B-His) as previously reported (Gauger and Gold-ATP present. Nonetheless, together these results suggest that the association of APP with microtubules is stein, 1993; Diefenbach et al., 1998). In contrast, the C-terminal tail of the kinesin-II subunit, KIF3A (KIF3A-His) strongly dependent on KLC. It is surprising that the relative dependence of APP association with microtubules or another kinesin-like motor, KIF21A, or GFP alone did not bind GST-KLC1 and GST-KLC2. We also tested the upon KLC1 and KLC2 is different than might be expected from the coimmunoprecipitation experiments, which binding of APP-GFP to GST-KLC1 using five different buffer conditions including high salt concentrations (see suggest that both KLC1 and KLC2 can exist in a complex Immunoblotting with 4G8 also gave the same result; that is, there is a significant decrease in the amount of APP brain extracts from the KLC1 mutant mice was normal (e.g., Figure 3, HSS) , the amount of APP present in sciatic that is present in the sciatic nerves of the KLC1 mutant. We also probed the sciatic nerve extracts for synaptic nerves of KLC1 mutants was significantly reduced com- 
Experimental Procedures
GST Binding Assay GST binding assays were done as previously described (Tai et al., Antibodies 1999) with minor modifications. Purified GST, GST-KLC1, and GSTFor Western blots, the monoclonal antibody 63-90 (Stenoien and KLC2 bound to glutathione agarose beads were incubated with 10 Brady, 1997), which recognizes KLC1 and KLC2 was used at 1:1000, g of indicated purified fusion protein in 150 l buffer B (20 mM the polyclonal KIF5A, KIF5B, and KIF5C antibodies (prepared by C.
Tris-Cl [pH 7.5], 50 mM KCl, 100 mM NaCl, 2 mM CaCl 2 , 2 mM MgCl 2 , Xia and G. Stokin, unpublished data) were used at 1:100, the APP 5 mM DTT, 1% BSA, and protease inhibitors) for 1 hr at 4ЊC. For monoclonal antibody 22C11 (Chemicon) was used at 1:500, the 4G8 the antibody inhibition experiments, the antibody was prebound to APP monoclonal antibody (Syntek) was used at 1:500, the tubulin the beads for 1 hr at 4ЊC and then incubated for 1 hr with the monoclonal antibody (DM1A, Sigma) was used at 1:5000, the cytoindicated protein. The unbound protein (in 150 l total volume) was plasmic dynein intermediate chain (DIC) monoclonal antibody saved, and the beads were washed three times with buffer B. Bound (Chemicon) was used at 1:1000, the GFP monoclonal antibody proteins were eluted with 50 l of elution buffer (50 mM glutathione, (Clonetech) was used at 1:500, the His-tag antibody (Qiagen) was 50 mM Tris-Cl [pH 8.0]). The bound (50 l) and unbound (50 l, i.e., used at 1:500, the KIF3A monoclonal antibody (K2.4, Babco) was one-third of total volume) proteins were then analyzed by SDSused at 1:1000, the synaptophysin monoclonal antibody (SY38, PAGE followed by Western blotting. We also tested the binding of Boehringer) was used at 1:200, the GAP43 monoclonal antibody APP-GFP or GFP alone to either GST-KLC1 or GST using four other (Boehringer) was used at 1:1000, the synaptotagmin monoclonal buffers than buffer B, namely (1) buffer B without Ca 2ϩ , (2) buffer B antibody (Stressgen) was used at 1:500, and the actin monoclonal plus 500 mM NaCl plus 1% NP-40, (3) buffer A from sucrose antibody (Sigma) was used at 1:5000. The KLC1 and KLC2 specific gradients ( were sacrificed, and the proximal and distal halves of the nerve KLC1 littermates were homogenized in PEM buffer (80 mM PIPES flanking the ligature were dissected, pooled, and homogenized as [pH 6.8], 2 mM MgCl 2 , 2 mM EGTA) containing 1% TX-100 and described above; the unligated nerve was treated similarly. The protease inhibitors. Equal volumes of the pellet (containing microtuprotein concentration was measured and equal amounts of protein bules and sedimented proteins) and supernatant were analyzed on loaded onto SDS-polyacrylamide gels and analyzed by Western SDS-PAGE followed by Western analyses.
analyses.
Purification of Fusion Proteins
The GST fusion proteins (GST, GST-KLC1, and GST-KLC2) were Acknowledgments purified as previously described (Rahman et al., 1998) 
